AS
AKKARAJU SRINIVAS disclosed purchase in Kalaris Therapeutics Inc
AKKARAJU SRINIVAS disclosed a purchase transaction in Kalaris Therapeutics Inc (KLRS) on 2026-05-22.
Action
Purchase
Capital
$1,179,969 reported value
Insider Form 4 Activity1 evidence source
Why it matters
This signal is anchored to the Form 4 disclosure date from Dataroma insider data.